Sensorion Announces the Availability of Its Financial Report for the 1st Half of 2023
26.09.2023 - Regulatory News: Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, Sensorion ...
Source: wallstreet-online.de